{"name":"Acumen Pharmaceuticals","permalink":"acumen-pharmaceuticals","crunchbase_url":"http://www.crunchbase.com/company/acumen-pharmaceuticals","homepage_url":"http://www.acumenpharm.com","blog_url":"","blog_feed_url":"","twitter_username":"","category_code":"biotech","number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"deadpooled_year":null,"deadpooled_month":null,"deadpooled_day":null,"deadpooled_url":null,"tag_list":"","alias_list":"","email_address":"","phone_number":"1-925-368-8508","description":"","created_at":"Fri Apr 30 04:11:04 UTC 2010","updated_at":"Fri Apr 30 04:22:03 UTC 2010","overview":"<p>Acumen Pharmaceuticals is a discovery stage biotechnology company focused on discovering and developing in partnership with leading pharmaceutical companies best in class therapeutics and diagnostics for Alzheimer&#8217;s disease. Acumen owns or has exclusive license to a broad set of patents, related intellectual property and drug development capabilities relating to amyloid beta soluble oligomers, now widely believed to be an underlying cause of Alzheimer&#8217;s disease. Acumen is partnered with Merck &amp; Co. for the development of certain monoclonal antibody therapeutics. NeuroVentures LLC and Biotechnology Value Fund LP have made investments in the company.</p>","image":{"available_sizes":[[[150,67],"assets/images/resized/0008/5429/85429v1-max-150x150.jpg"],[[155,70],"assets/images/resized/0008/5429/85429v1-max-250x250.jpg"],[[155,70],"assets/images/resized/0008/5429/85429v1-max-450x450.jpg"]],"attribution":null},"products":[],"relationships":[],"competitions":[],"providerships":[],"total_money_raised":"$1.5M","funding_rounds":[{"round_code":"unattributed","source_url":"","source_description":"Cap Funding Report","raised_amount":1500000,"raised_currency_code":"USD","funded_year":2006,"funded_month":8,"funded_day":17,"investments":[{"company":null,"financial_org":{"name":"NeuroVentures","permalink":"neuroventures","image":{"available_sizes":[[[150,20],"assets/images/resized/0006/1657/61657v1-max-150x150.jpg"],[[250,34],"assets/images/resized/0006/1657/61657v1-max-250x250.jpg"],[[423,59],"assets/images/resized/0006/1657/61657v1-max-450x450.jpg"]],"attribution":null}},"person":null}]}],"investments":[],"acquisition":null,"acquisitions":[],"offices":[{"description":"","address1":"4435 North First Street, # 360","address2":"","zip_code":"94551","city":"Livermore","state_code":"CA","country_code":"USA","latitude":null,"longitude":null}],"milestones":[],"ipo":null,"video_embeds":[],"screenshots":[{"available_sizes":[[[150,124],"assets/images/resized/0008/5430/85430v1-max-150x150.jpg"],[[250,207],"assets/images/resized/0008/5430/85430v1-max-250x250.jpg"],[[450,373],"assets/images/resized/0008/5430/85430v1-max-450x450.jpg"]],"attribution":null}],"external_links":[]}